At the end of June, the European Society of Human Reproduction and Embryology (ESHRE) organizes its 37th Annual Meeting and OXOLIFE will participate in it. It is fantastic news that the ESHRE has accepted our communication “Oral administration of OXO-001 to a swine model improves embryo implantation rate”, which contains information about OXO-001 in vivo preclinical studies.